Aier(SZ:300015) Xin Lang Cai Jing·2025-10-14 05:54Core Viewpoint - Aier Eye Hospital's stock has shown fluctuations, with a recent increase of 2.08% and a current price of 12.78 CNY per share, while the company has experienced a year-to-date decline of 2.38% [1] Financial Performance - For the first half of 2025, Aier Eye Hospital reported a revenue of 11.507 billion CNY, representing a year-on-year growth of 9.12%, and a net profit attributable to shareholders of 2.051 billion CNY, with a slight increase of 0.05% [2] - Cumulative cash dividends since Aier Eye Hospital's A-share listing amount to 7.12 billion CNY, with 3.6 billion CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders decreased to 343,900, while the average circulating shares per person increased to 23,064 [2] - The top ten circulating shareholders include significant entities such as Hong Kong Central Clearing Limited and various ETFs, with notable changes in their holdings [3] Market Activity - The stock's trading volume reached 790 million CNY with a turnover rate of 0.79%, indicating active market participation [1] - The net inflow of main funds was 56.118 million CNY, with large orders contributing significantly to both buying and selling activities [1] Business Overview - Aier Eye Hospital, established on January 24, 2003, specializes in various ophthalmic medical services, with its revenue composition including refractive projects (40.13%), vision services (23.64%), and cataract projects (15.48%) [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical services sector, and is involved in several concept sectors such as medical aesthetics and smart healthcare [1]